- Home
- / Catalyst Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Catalyst Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$21.8
2024-10-29
Market Capitalization
$2.6 B
2024-10-29
Revenue
$491.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jul 14, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 500.0K | 119.1M | 140.8M | 214.2M | 398.2M | 491.7M | |||||||
| Cost of goods sold | 17.0M | 21.9M | 34.4M | 52.0M | 68.8M | ||||||||
| Gross profit | 102.0M | 179.8M | 346.2M | 422.9M | |||||||||
| Gross profit margin, % | 85.7% | 83.9% | 86.9% | 86.0% | |||||||||
| General and administrative expense | 2.7M | 2.6M | 2.2M | 4.5M | 8.6M | 7.9M | 7.3M | 15.9M | 44.2M | 49.6M | 58.2M | 133.7M | 177.7M |
| Operating expense total | 6.1M | 5.2M | 10.3M | 14.6M | 20.4M | 19.3M | 18.7M | 35.8M | 60.7M | 66.6M | 78.0M | 259.4M | 227.8M |
| Depreciation and amortization | 32.6M | ||||||||||||
| EBIT | (6.1M) | (5.2M) | (10.3M) | (14.6M) | (20.4M) | (19.3M) | (18.7M) | (35.3M) | 41.3M | 52.4M | 101.8M | 86.8M | 195.1M |
| EBIT margin, % | -7059.0% | 34.7% | 47.5% | 21.8% | 39.7% | ||||||||
| Interest income | 11.0K | 15.0K | 47.4K | ||||||||||
| Interest expense | 705.0K | 1.4M | |||||||||||
| Pre tax profit | (6.4M) | (4.1M) | (12.2M) | (15.5M) | (20.2M) | (18.1M) | (18.4M) | (34.0M) | 41.9M | 52.7M | 104.7M | 94.5M | 216.3M |
| Income tax expense | (33.1M) | 13.2M | 21.6M | 23.1M | 52.4M | ||||||||
| Net Income | (6.4M) | (4.1M) | (12.2M) | (15.5M) | (20.2M) | (18.1M) | (18.4M) | (34.0M) | 75.0M | 39.5M | 83.1M | 71.4M | 163.9M |
| EPS | 0.8 | 0.6 | 1.3 |